European Contraception Policy Atlas 2020
If you missed the on-line launch of the Atlas today, YouTube is here to help: https://youtu.be/5sT5mKS-UtI
If you missed the on-line launch of the Atlas today, YouTube is here to help: https://youtu.be/5sT5mKS-UtI A Behavior and Attitudes survey carried out on behalf of Bayer Healthcare found that in the last two years, approximately 17% of women had accessed EC, with 5% accessing it more than once. Read more about the survey here.
June 2017. A new survey and a web discussion have provided new data about whether and how Italian women’s awareness of and access to EC has changed following the availability of UPA EC without a prescription in 2015. According to this data, 90% of the women consulted consider EC useful and 91% think it is effective; but on…

February 2023. In Peru, the long-awaited hearing of the emergency contraception case took place in the Constitutional Court on February 28, 2023. The court discussed if the provision of emergency contraception pills (ECPs) through the public health network, is in accordance with Constitutional law. In Peru, ECPs are allowed for sale in pharmacies (paid out…

November. According to Kyodo news agency, the trial of a new modality to dispense emergency contraception pills (ECPs) without a prescription in Japan, began on November 28. The Health, Labour and Welfare Ministry will test out this modality in 145 pharmacies (of more than 60.000 in the country). Japan is one of the few northern hemisphere countries where…
October 2021. The International Federation of Gynecology and Obstetrics (FIGO) calls on its members to commit to discussing sexual and reproductive health, including contraception, infection prevention and safe sex, in their conversations with young people, girls, and boys. Around the world, complications during pregnancy and childbirth are the leading cause of death for 15–19-year-old girls….
The European Medicines Agency (EMA) released the following statement today: “The European Medicines Agency has concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether increased bodyweight affects the effectiveness of these medicines in preventing unintended pregnancy following unprotected sexual intercourse or contraceptive failure. The Agency’s Committee for Medicinal Products for Human…
Menú